Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
subcutaneous
Pharma
Biogen taps Alteogen for help developing 2 subQ biologics
After attracting GSK with its subcutaneous delivery tech earlier this year, South Korea’s Alteogen has snared another Big Pharma partner in Biogen.
Fraiser Kansteiner
Mar 25, 2026 10:55am
GSK licenses Alteogen enzyme in bid to develop subQ Jemperli
Jan 20, 2026 2:26pm
Roche's bispecific Lunsumio goes subcutaneous
Dec 22, 2025 10:15am
Argenx cans Vyvgart trials in thyroid eye disease over futility
Dec 15, 2025 10:00am
Halozyme CEO targets new deals as IRA uncertainty subsides
Oct 14, 2025 9:40am
Halozyme buys Elektrofi for up to $900M
Oct 1, 2025 2:36pm
